Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › OH › PARMA HEIGHTS › MED CARE GROUP INC

MED CARE GROUP INC

NPI: 1467571976 · PARMA HEIGHTS, OH 44130 · Internal Medicine Physician · NPI assigned 03/28/2007

$7.36M
Total Medicaid Paid
473,896
Total Claims
305,173
Beneficiaries
191
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPOPA, CARMEN (OWNER)
NPI Enumeration Date03/28/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 45,576 $834K
2019 43,597 $827K
2020 53,908 $1.03M
2021 52,379 $1.20M
2022 92,109 $1.36M
2023 122,909 $1.49M
2024 63,418 $618K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 27,844 20,855 $1.55M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 23,619 15,432 $905K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 12,866 5,174 $590K
96375 Therapeutic injection; each additional sequential IV push 13,023 4,767 $556K
99051 17,747 13,639 $329K
86769 8,366 3,746 $327K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 7,603 6,613 $299K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 7,605 3,170 $245K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2,692 2,476 $198K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 3,769 3,592 $194K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 8,510 7,437 $165K
99401 7,418 6,073 $137K
80305 14,369 12,699 $124K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 3,945 3,326 $120K
J3490 Unclassified drugs 8,985 2,166 $106K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 4,942 3,777 $76K
83880 3,224 2,043 $73K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 5,565 2,477 $63K
96361 Intravenous infusion, hydration; each additional hour 3,988 1,483 $52K
99406 5,917 4,828 $48K
83036 Hemoglobin; glycosylated (A1C) 6,967 6,349 $46K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,326 2,055 $43K
36415 Collection of venous blood by venipuncture 20,499 14,047 $40K
93000 2,882 2,548 $40K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,253 755 $35K
80061 Lipid panel 3,715 3,360 $35K
99442 978 807 $34K
80051 7,697 4,807 $33K
99050 2,183 1,664 $33K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 6,597 4,307 $33K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 907 887 $33K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 525 499 $32K
84443 Thyroid stimulating hormone (TSH) 2,957 2,600 $32K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,468 2,221 $29K
82784 1,645 1,430 $29K
J2300 Injection, nalbuphine hydrochloride, per 10 mg 6,776 2,930 $26K
82607 2,868 2,499 $26K
82565 7,788 4,855 $25K
84450 7,778 4,846 $25K
82310 7,780 4,848 $25K
82247 7,773 4,846 $24K
84460 7,791 4,848 $23K
82040 7,772 4,840 $23K
84075 7,762 4,840 $23K
82746 2,294 2,010 $20K
84520 7,787 4,851 $19K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 709 637 $18K
J1885 Injection, ketorolac tromethamine, per 15 mg 10,803 5,264 $18K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 323 303 $18K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 659 625 $17K
84155 7,774 4,847 $17K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,055 1,303 $17K
94016 1,184 1,054 $15K
94010 911 856 $15K
83735 3,474 1,946 $14K
82552 1,575 1,163 $13K
84484 1,609 1,181 $12K
83874 1,634 1,180 $11K
J0696 Injection, ceftriaxone sodium, per 250 mg 5,567 2,411 $10K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 4,730 2,124 $10K
96127 2,741 2,529 $10K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 6,764 3,618 $10K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 721 346 $9K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 473 444 $8K
83550 1,463 1,289 $8K
99201 404 367 $8K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 8,259 4,083 $7K
99441 294 255 $7K
83540 1,675 1,472 $7K
82550 1,568 1,161 $6K
80053 Comprehensive metabolic panel 751 532 $6K
94060 123 102 $5K
99223 Prolong inpt eval add15 m 98 84 $5K
85049 2,173 1,269 $4K
0001A 47 46 $4K
J3475 Injection, magnesium sulfate, per 500 mg 3,801 1,603 $4K
J0456 Injection, azithromycin, 500 mg 1,662 696 $4K
82728 473 415 $4K
81003 2,246 1,951 $4K
90674 149 143 $3K
86703 490 386 $3K
J2550 Injection, promethazine hcl, up to 50 mg 1,646 543 $3K
J7050 Infusion, normal saline solution, 250 cc 7,940 3,323 $3K
82553 1,551 1,145 $3K
87807 364 307 $3K
99384 41 39 $3K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 139 102 $3K
90688 206 194 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg 3,770 1,632 $3K
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes 624 556 $3K
0003A 35 32 $3K
99385 42 41 $3K
99233 Prolong inpt eval add15 m 105 50 $3K
85041 2,052 1,215 $2K
96367 108 67 $2K
85014 2,168 1,267 $2K
J7030 Infusion, normal saline solution , 1000 cc 1,418 814 $2K
85018 2,169 1,268 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 8,324 3,744 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 123 89 $2K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 31 31 $2K
J1040 Injection, methylprednisolone acetate, 80 mg 173 151 $2K
87905 242 205 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 284 140 $2K
82043 308 282 $2K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 60 36 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 103 99 $1K
86677 167 139 $1K
83721 225 212 $1K
86780 176 128 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 33 18 $1K
85048 2,071 1,153 $1K
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory 42 40 $1K
86318 102 89 $1K
J1940 Injection, furosemide, up to 20 mg 1,224 430 $1K
93923 14 12 $1K
0013A 17 14 $1K
84436 455 407 $1K
83690 285 255 $1K
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination 39 38 $959.41
90715 26 26 $852.16
J3370 Injection, vancomycin hcl, 500 mg 110 38 $807.01
S0028 Injection, famotidine, 20 mg 3,842 1,714 $593.64
81025 124 115 $538.93
G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) 27 26 $538.26
82150 291 256 $512.05
J2270 Injection, morphine sulfate, up to 10 mg 239 132 $502.16
82947 112 108 $432.70
99239 Hospital discharge day management, more than 30 minutes 13 12 $406.60
99238 Hospital discharge day management, 30 minutes or less 15 14 $341.15
87899 132 123 $273.45
83718 224 210 $210.31
86580 34 27 $184.57
82465 199 194 $169.30
84478 225 210 $152.17
94375 136 126 $135.60
85380 14 12 $131.38
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 1,387 917 $128.31
J3411 Injection, thiamine hcl, 100 mg 27 18 $123.00
J2765 Injection, metoclopramide hcl, up to 10 mg 105 66 $115.04
94664 18 14 $88.18
84550 29 29 $81.86
85007 28 12 $79.80
G0008 Administration of influenza virus vaccine 14 13 $75.04
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 446 269 $65.13
3044F 189 126 $40.00
36416 12 12 $30.30
99408 277 248 $20.24
J1956 Injection, levofloxacin, 250 mg 31 14 $12.43
J7042 5% dextrose/normal saline (500 ml = 1 unit) 16 13 $7.90
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 85 54 $5.56
G0442 Annual alcohol misuse screening, 5 to 15 minutes 61 56 $2.83
J7614 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg 31 16 $0.40
91300 168 144 $0.32
3017F 1,324 826 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 1,137 728 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 942 608 $0.00
G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) 525 323 $0.00
H0049 Alcohol and/or drug screening 566 535 $0.00
3008F 2,198 1,351 $0.00
1125F 37 26 $0.00
1036F 49 42 $0.00
94760 35 26 $0.00
3079F 151 110 $0.00
1111F 2,359 1,442 $0.00
3075F 124 85 $0.00
3080F 184 143 $0.00
J7615 Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg 151 98 $0.00
91301 22 18 $0.00
3074F 157 120 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 62 54 $0.00
G9908 Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) 64 54 $0.00
G8950 Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented 34 31 $0.00
94761 14 12 $0.00
J7616 31 15 $0.00
4004F 1,260 814 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 340 256 $0.00
G0030 Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user 180 125 $0.00
G8783 Normal blood pressure reading documented, follow-up not required 1,280 850 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 2,001 1,312 $0.00
G8482 Influenza immunization administered or previously received 692 455 $0.00
G9899 Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed 176 102 $0.00
G8484 Influenza immunization was not administered, reason not given 152 134 $0.00
G0444 Annual depression screening, 5 to 15 minutes 72 66 $0.00
3077F 235 188 $0.00
G8780 Counseling for diet and physical activity performed 257 228 $0.00
G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.) 75 72 $0.00
G9905 Patient not screened for tobacco use 75 66 $0.00
3078F 180 135 $0.00
H0050 Alcohol and/or drug services, brief intervention, per 15 minutes 32 32 $0.00
99359 Prolong nursin fac eval 15m 13 13 $0.00